Withania somnifera: an Indian ginseng SK Kulkarni, A Dhir Progress in neuro-psychopharmacology and biological psychiatry 32 (5), 1093-1105, 2008 | 526 | 2008 |
Berberine: a plant alkaloid with therapeutic potential for central nervous system disorders SK Kulkarni, A Dhir Phytotherapy Research: An International Journal Devoted to Pharmacological …, 2010 | 437 | 2010 |
Pentylenetetrazol (PTZ) kindling model of epilepsy A Dhir Current protocols in neuroscience 58 (1), 9.37. 1-9.37. 12, 2012 | 331 | 2012 |
On the mechanism of antidepressant-like action of berberine chloride SK Kulkarni, A Dhir European Journal of Pharmacology 589 (1-3), 163-172, 2008 | 262 | 2008 |
Nitric oxide and major depression A Dhir, SK Kulkarni Nitric oxide 24 (3), 125-131, 2011 | 256 | 2011 |
Potentials of curcumin as an antidepressant SK Kulkarni, A Dhir, KK Akula The Scientific World Journal 9 (1), 1233-1241, 2009 | 239 | 2009 |
An overview of curcumin in neurological disorders SK Kulkarni, A Dhir Indian journal of pharmaceutical sciences 72 (2), 149, 2010 | 214 | 2010 |
Natural polyphenols in the management of major depression L Pathak, Y Agrawal, A Dhir Expert opinion on investigational drugs 22 (7), 863-880, 2013 | 166 | 2013 |
Involvement of nitric oxide (NO) signaling pathway in the antidepressant action of bupropion, a dopamine reuptake inhibitor A Dhir, SK Kulkarni European journal of pharmacology 568 (1-3), 177-185, 2007 | 156 | 2007 |
Effect of various classes of antidepressants in behavioral paradigms of despair SK Kulkarni, A Dhir Progress in Neuro-Psychopharmacology and Biological Psychiatry 31 (6), 1248-1254, 2007 | 142 | 2007 |
Possible involvement of L-arginine-nitric oxide (NO)-cyclic guanosine monophosphate (cGMP) signaling pathway in the antidepressant activity of berberine chloride SK Kulkarni, A Dhir European journal of pharmacology 569 (1-2), 77-83, 2007 | 142 | 2007 |
Current investigational drugs for major depression SK Kulkarni, A Dhir Expert opinion on investigational drugs 18 (6), 767-788, 2009 | 126 | 2009 |
Involvement of l-arginine–nitric oxide–cyclic guanosine monophosphate pathway in the antidepressant-like effect of venlafaxine in mice A Dhir, SK Kulkarni Progress in Neuro-Psychopharmacology and Biological Psychiatry 31 (4), 921-925, 2007 | 120 | 2007 |
Effect of cyclooxygenase inhibitors on pentylenetetrazol (PTZ)-induced convulsions: Possible mechanism of action A Dhir, PS Naidu, SK Kulkarni Progress in Neuro-Psychopharmacology and Biological Psychiatry 30 (8), 1478-1485, 2006 | 104 | 2006 |
Persistent behavior deficits, neuroinflammation, and oxidative stress in a rat model of acute organophosphate intoxication M Guignet, K Dhakal, BM Flannery, BA Hobson, D Zolkowska, A Dhir, ... Neurobiology of disease 133, 104431, 2020 | 97 | 2020 |
Mechanisms of action of antiseizure drugs RJ Porter, A Dhir, RL Macdonald, MA Rogawski Handbook of clinical neurology 108, 663-681, 2012 | 94 | 2012 |
Effect of Withania somnifera Dunal root extract against pentylenetetrazol seizure threshold in mice: Possible involvement of GABAergic system SK Kulkarni, KK Akula, A Dhir CSIR, 2008 | 91 | 2008 |
Neuroprotective effect of nimesulide, a preferential COX-2 inhibitor, against pentylenetetrazol (PTZ)-induced chemical kindling and associated biochemical parameters in mice A Dhir, PS Naidu, SK Kulkarni Seizure 16 (8), 691-697, 2007 | 89 | 2007 |
Protective effect of naproxen (non-selective COX-inhibitor) or rofecoxib (selective COX-2 inhibitor) on immobilization stress-induced behavioral and biochemical alterations in mice A Dhir, SSV Padi, PS Naidu, SK Kulkarni European journal of pharmacology 535 (1-3), 192-198, 2006 | 86 | 2006 |
Rofecoxib, a selective cyclooxygenase-2 (COX-2) inhibitor increases pentylenetetrazol seizure threshold in mice: possible involvement of adenosinergic mechanism KK Akula, A Dhir, SK Kulkarni Epilepsy research 78 (1), 60-70, 2008 | 79 | 2008 |